exactly, so that looks more than likely SYD will take up the offer. to me, they get the monopoly at a discount,but it dilutes their earnings,regardless . cheers crazypunter
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%